• wonderlic tests
  • EXAM REVIEW
  • NCCCO Examination
  • Summary
  • Class notes
  • QUESTIONS & ANSWERS
  • NCLEX EXAM
  • Exam (elaborations)
  • Study guide
  • Latest nclex materials
  • HESI EXAMS
  • EXAMS AND CERTIFICATIONS
  • HESI ENTRANCE EXAM
  • ATI EXAM
  • NR AND NUR Exams
  • Gizmos
  • PORTAGE LEARNING
  • Ihuman Case Study
  • LETRS
  • NURS EXAM
  • NSG Exam
  • Testbanks
  • Vsim
  • Latest WGU
  • AQA PAPERS AND MARK SCHEME
  • DMV
  • WGU EXAM
  • exam bundles
  • Study Material
  • Study Notes
  • Test Prep

NR565 Advanced Pharmacology Fundamentals Week 6 Quiz / Exam Questions 2026/2027 LATEST UPDATE

NR AND NUR Exams Nov 26, 2024
Preview Mode - Purchase to view full document
Loading...

Loading study material viewer...

Page 0 of 0

Document Text

Methylxanthines

Who is at risk for toxicity and why?

Older patients are at much higher risk for toxicity when taking methylxanthines.

Systemic anticholinergics are included in Beers Criteria for Potentially Inappropriate Use in 

Older Adults; they should not be substituted for inhaled anticholinergics

These drugs are contraindicated for patients with untreated seizure disorders or peptic ulcer 

disease.

Use with caution in patients with heart disease (can exacerbate dysrhythmias), liver dysfunction 

(increased risk for toxicity), peptic ulcer disease (can exacerbate condition), or seizure disorders 

(can exacerbate seizures).

Asthma & COPD

Step 1 therapy

Complete this sentence: Manage with a ______ as needed.

SABA

symptoms associated with mild persistent asthma

Symptoms: More than 2 d/wk but less than daily

nighttime awakenings:

3–4 times/month

SABA use= more than 2 days/week but less than daily AND no more than 1 time on any day.

Effect on activity= minimal activity limitation.

Risk for exacerbations requiring systemic glucocorticoids= 2 or more times/6 months OR 

wheezing lasting more than 1 day 4 or more times/year (2 or more times/year for 5 y.o. & up).

symptoms associated with moderate persistent asthma

Symptoms: Daily

nighttime awakenings: 

3-4 times/month More than once/week but less than nightly

SABA use= daily.

Effect on activity= some activity limitation.

Risk for exacerbations requiring systemic glucocorticoids= increased frequency & intensity of

exacerbations or wheezing.

symptoms associated with severe persistent asthma

symptoms: several times daily

nighttime awakenings: often nightly

SABA use= several times a day

Effect on activity= severe activity limitation.

Risk for exacerbations requiring systemic glucocorticoids= even greater increased frequency & 

intensity

of exacerbations or wheezing.

symptoms associated with intermittent asthma

symptoms: 2d/wk or less 

nighttime awakenings: 2 times/month or less

effect on activity: none

SABA use= 2 days/week or less.

Risk for exacerbations requiring systemic glucocorticoids= 0-1 time/year.

What are some examples of a SABA?

albuterol, levalbuterol

benefits of SABA

Rescue inhaler, all asthma patients should have a SABA, they are for prophylaxis of exerciseinduced bronchospasms and to relieve ongoing asthma attacks and COPD exacerbations

Download Study Material

Buy This Study Material

$19.00
Buy Now
  • Immediate download after payment
  • Available in the pdf format
  • 100% satisfaction guarantee

Study Material Information

Category: NR AND NUR Exams
Description:

NR565 Advanced Pharmacology Fundamentals Week 6 Quiz / Exam Questions 2026/2027 LATEST UPDATE

UNLOCK ACCESS $19.00